vs

Side-by-side financial comparison of ACTELIS NETWORKS INC (ASNS) and Insight Molecular Diagnostics Inc. (IMDX). Click either name above to swap in a different company.

ACTELIS NETWORKS INC is the larger business by last-quarter revenue ($1.4M vs $1.1M, roughly 1.2× Insight Molecular Diagnostics Inc.). ACTELIS NETWORKS INC runs the higher net margin — -184.5% vs -2015.4%, a 1830.9% gap on every dollar of revenue. On growth, ACTELIS NETWORKS INC posted the faster year-over-year revenue change (28.6% vs -23.4%). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs 37.2%).

Actelis Networks Inc develops and manufactures high-performance broadband access networking solutions for telecom operators, enterprises and government entities. Its core products include Ethernet over copper systems delivering cost-effective high-speed connectivity over existing copper infrastructure, with key markets across North America, Europe and the Asia-Pacific.

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

ASNS vs IMDX — Head-to-Head

Bigger by revenue
ASNS
ASNS
1.2× larger
ASNS
$1.4M
$1.1M
IMDX
Growing faster (revenue YoY)
ASNS
ASNS
+52.0% gap
ASNS
28.6%
-23.4%
IMDX
Higher net margin
ASNS
ASNS
1830.9% more per $
ASNS
-184.5%
-2015.4%
IMDX
Faster 2-yr revenue CAGR
IMDX
IMDX
Annualised
IMDX
154.4%
37.2%
ASNS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASNS
ASNS
IMDX
IMDX
Revenue
$1.4M
$1.1M
Net Profit
$-2.5M
$-23.0M
Gross Margin
35.1%
42.5%
Operating Margin
-122.3%
-2057.5%
Net Margin
-184.5%
-2015.4%
Revenue YoY
28.6%
-23.4%
Net Profit YoY
-40.1%
31.5%
EPS (diluted)
$-5.08
$-0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASNS
ASNS
IMDX
IMDX
Q4 25
$1.4M
$1.1M
Q3 25
$643.0K
$260.0K
Q2 25
$941.0K
$518.0K
Q1 25
$721.0K
$2.1M
Q4 24
$1.1M
$1.5M
Q3 24
$2.5M
$115.0K
Q2 24
$3.4M
$104.0K
Q1 24
$726.0K
$176.0K
Net Profit
ASNS
ASNS
IMDX
IMDX
Q4 25
$-2.5M
$-23.0M
Q3 25
$-2.0M
$-10.9M
Q2 25
$-1.9M
$-9.7M
Q1 25
$-1.9M
$-6.7M
Q4 24
$-1.8M
$-33.5M
Q3 24
$-511.0K
$-13.5M
Q2 24
$-78.0K
$-4.5M
Q1 24
$-2.0M
$-9.1M
Gross Margin
ASNS
ASNS
IMDX
IMDX
Q4 25
35.1%
42.5%
Q3 25
28.5%
53.5%
Q2 25
32.4%
67.6%
Q1 25
34.8%
62.0%
Q4 24
34.3%
40.0%
Q3 24
68.6%
43.5%
Q2 24
56.6%
48.1%
Q1 24
30.3%
25.6%
Operating Margin
ASNS
ASNS
IMDX
IMDX
Q4 25
-122.3%
-2057.5%
Q3 25
-300.0%
-4249.2%
Q2 25
-188.4%
-1900.0%
Q1 25
-251.3%
-318.0%
Q4 24
-154.0%
-2262.9%
Q3 24
-12.5%
-11752.2%
Q2 24
1.9%
-4453.8%
Q1 24
-257.7%
-5265.3%
Net Margin
ASNS
ASNS
IMDX
IMDX
Q4 25
-184.5%
-2015.4%
Q3 25
-307.9%
-4174.6%
Q2 25
-202.0%
-1880.7%
Q1 25
-258.0%
-312.0%
Q4 24
-169.4%
-2255.1%
Q3 24
-20.1%
-11733.0%
Q2 24
-2.3%
-4355.8%
Q1 24
-273.6%
-5186.9%
EPS (diluted)
ASNS
ASNS
IMDX
IMDX
Q4 25
$-5.08
$-0.75
Q3 25
$-0.17
$-0.34
Q2 25
$-0.21
$-0.30
Q1 25
$-0.22
$-0.26
Q4 24
$-7.90
$-2.19
Q3 24
$-0.09
$-0.98
Q2 24
$-0.01
$-0.36
Q1 24
$-0.50
$-1.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASNS
ASNS
IMDX
IMDX
Cash + ST InvestmentsLiquidity on hand
$4.1M
$11.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.8M
$-31.5M
Total Assets
$9.5M
$25.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASNS
ASNS
IMDX
IMDX
Q4 25
$4.1M
$11.6M
Q3 25
$1.5M
$18.7M
Q2 25
$393.0K
$24.3M
Q1 25
$1.1M
$31.0M
Q4 24
$2.0M
$8.6M
Q3 24
$2.2M
$3.4M
Q2 24
$2.4M
$9.3M
Q1 24
$1.4M
$5.6M
Total Debt
ASNS
ASNS
IMDX
IMDX
Q4 25
Q3 25
$150.0K
Q2 25
$150.0K
Q1 25
$150.0K
Q4 24
$150.0K
Q3 24
Q2 24
Q1 24
$148.0K
Stockholders' Equity
ASNS
ASNS
IMDX
IMDX
Q4 25
$4.8M
$-31.5M
Q3 25
$3.0M
$-9.2M
Q2 25
$1.3M
$1.1M
Q1 25
$2.6M
$10.2M
Q4 24
$3.0M
$-12.3M
Q3 24
$3.1M
$9.7M
Q2 24
$1.1M
$22.7M
Q1 24
$-1.7M
$11.6M
Total Assets
ASNS
ASNS
IMDX
IMDX
Q4 25
$9.5M
$25.8M
Q3 25
$6.9M
$43.9M
Q2 25
$6.0M
$50.5M
Q1 25
$7.1M
$60.4M
Q4 24
$8.2M
$35.1M
Q3 24
$8.8M
$70.2M
Q2 24
$8.4M
$74.7M
Q1 24
$10.5M
$71.0M
Debt / Equity
ASNS
ASNS
IMDX
IMDX
Q4 25
Q3 25
0.05×
Q2 25
0.12×
Q1 25
0.06×
Q4 24
0.05×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASNS
ASNS
IMDX
IMDX
Operating Cash FlowLast quarter
$-2.1M
$-5.5M
Free Cash FlowOCF − Capex
$-7.0M
FCF MarginFCF / Revenue
-616.7%
Capex IntensityCapex / Revenue
129.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-25.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASNS
ASNS
IMDX
IMDX
Q4 25
$-2.1M
$-5.5M
Q3 25
$-2.4M
$-4.5M
Q2 25
$-1.0M
$-6.3M
Q1 25
$-2.2M
$-5.9M
Q4 24
$-1.8M
$-5.4M
Q3 24
$-2.4M
$-5.5M
Q2 24
$-2.1M
$-6.0M
Q1 24
$-203.0K
$-3.8M
Free Cash Flow
ASNS
ASNS
IMDX
IMDX
Q4 25
$-7.0M
Q3 25
$-5.6M
Q2 25
$-6.6M
Q1 25
$-6.2M
Q4 24
$-5.6M
Q3 24
$-5.6M
Q2 24
$-6.2M
Q1 24
$-204.0K
$-3.9M
FCF Margin
ASNS
ASNS
IMDX
IMDX
Q4 25
-616.7%
Q3 25
-2135.4%
Q2 25
-1279.5%
Q1 25
-288.4%
Q4 24
-374.5%
Q3 24
-4884.3%
Q2 24
-5931.7%
Q1 24
-28.1%
-2189.8%
Capex Intensity
ASNS
ASNS
IMDX
IMDX
Q4 25
129.9%
Q3 25
403.8%
Q2 25
67.4%
Q1 25
14.4%
Q4 24
0.0%
14.4%
Q3 24
0.0%
75.7%
Q2 24
0.0%
183.7%
Q1 24
0.1%
13.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASNS
ASNS

Europe Middle East And Africa$1.1M83%
Other$228.0K17%

IMDX
IMDX

Segment breakdown not available.

Related Comparisons